|
CDC25C expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.645800E-01 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.853000E-01 |
| Normal-vs-Stage2 |
7.691800E-01 |
| Normal-vs-Stage3 |
2.265400E-01 |
| Normal-vs-Stage4 |
9.302200E-02 |
| Stage1-vs-Stage2 |
5.236000E-01 |
| Stage1-vs-Stage3 |
4.400800E-01 |
| Stage1-vs-Stage4 |
1.698770E-01 |
| Stage2-vs-Stage3 |
2.786400E-01 |
| Stage2-vs-Stage4 |
1.053640E-01 |
| Stage3-vs-Stage4 |
7.359800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.167200E-01 |
| Normal-vs-AfricanAmerican |
6.138000E-01 |
| Normal-vs-Asian |
3.732600E-01 |
| Caucasian-vs-AfricanAmerican |
5.984600E-01 |
| Caucasian-vs-Asian |
6.375400E-01 |
| AfricanAmerican-vs-Asian |
8.442800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.773600E-02 |
| Normal-vs-Female |
4.584000E-01 |
| Male-vs-Female |
1.179040E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.873840E-01 |
| Normal-vs-Age(41-60Yrs) |
8.588600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.524570E-01 |
| Normal-vs-Age(81-100Yrs) |
2.417200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.355700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.229800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.901800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.951840E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.342000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.086800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.935800E-01 |
| Classical-VS-Follicular |
2.149700E-02 |
| Classical-VS-Other |
3.391800E-01 |
| Classical-VS-Normal |
1.791240E-01 |
| Tall-VS-Follicular |
1.659200E-01 |
| Tall-VS-Other |
4.607000E-01 |
| Tall-VS-Normal |
3.172600E-01 |
| Follicular-VS-Other |
8.466800E-01 |
| Follicular-VS-Normal |
9.414400E-01 |
| Other-VS-Normal |
8.526000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.524000E-01 |
| Normal-vs-N1 |
6.086200E-01 |
| N0-vs-N1 |
3.976800E-01 |
|
|
